Free shipping on all orders over $ 500

AM1241

Cat. No. M2012

All AbMole products are for research use only, cannot be used for human consumption.

AM1241 Structure
Size Price Availability
10mg USD 100  USD100 Out of stock
50mg USD 300  USD300 Out of stock
100mg USD 450  USD450 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AM-1241 is a potent and selective agonist for the cannabinoid receptor CB2, with a Ki of 3.4nM at CB2 and 80x selectivity over the related CB1 receptor. AM1241 exhibits high affinity and selectivity for CB2 receptors. It also exhibits high potency in vivo. AM1241 dose-dependently reversed tactile and thermal hypersensitivity produced by ligation of the L5 and L6 spinal nerves in rats. AM1241 also inhibited flinching and thermal hyperalgesia produced by hind paw capsaicin injection. AM1241 was also active in blocking spinal nerve ligation-induced tactile and thermal hypersensitivity in mice lacking CB1 receptors (CB1-/- mice), confirming that AM1241 reverses sensory hypersensitivity independent of actions at CB1 receptors. Treatment with AM-1241 reduced both spontaneous and evoked pain, as well as reducing the bone loss and subsequent fractures due to the tumor.

Chemical Information
Molecular Weight 503.33
Formula C22H22IN3O3
CAS Number 444912-48-5
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bingham B, et al. Br J Pharmacol. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.

[2] Shoemaker JL, et al. J Neurochem. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.

[3] Yao BB, et al. Br J Pharmacol. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

[4] Ibrahim MM, et al. Proc Natl Acad Sci U S A. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.

Related Cannabinoid Products
Org 27569

Org 27569 is a potent and selective allosteric modulator of the cannabinoid CB1 receptor.

CP 945598 hydrochloride

CP 945598 hydrochloride is a selective and high affinity CB1 antagonist (Ki values are 0.7 and 0.12 nM in binding and functional assays respectively).

AM-2201

AM-2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.

AM251

AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain.

BML-190

BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: AM1241 supplier, Cannabinoid, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.